Bone Biologics Corp Warrants
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BBLGW Company Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
BBLGW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BBLGW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BBLGW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BBLGW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BBLGW in WallStreetBets Daily Discussion
BBLGW News
Recent insights relating to BBLGW
CNBC Recommendations
Recent picks made for BBLGW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BBLGW
Corporate Flights
Flights by private jets registered to BBLGW
Our Analysis